Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms

NCT05206357 is registered in ClinicalTrials.gov with Genmab as lead sponsor.

NCT NCT05206357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05206357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
Lead sponsor
Genmab
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 4, 2022
Completion date
November 30, 2028
Enrollment
17 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma